Blog

VIDEO: Speaker compares single-agent vs. combination immunotherapy for melanoma – Healio

VIDEO: Speaker compares single-agent vs. combination immunotherapy for melanoma
Healio
NEW YORK — Mario Sznol, MD, professor of medicine at Yale Cancer Center, discusses whether single-agent or combination immunotherapy should be used to treat patients with melanoma at HemOnc Today Melanoma and Cutaneous Malignancies.

2017-04-09 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.